ANI Pharmaceuticals Inc. Surpasses Analyst Target Price of $83.12

ANI Pharmaceuticals Inc (ANIP) shares have crossed above the average analyst 12-month target price of $83.12, trading at $84.88/share. The average analyst target is based on 8 different analyst targets, ranging from $65 to $94. Investors should assess the company and decide whether the valuation has gotten stretched or if there is room for further growth.

ANI Pharmaceuticals Inc (ANIP) shares have surged above the average analyst 12-month target price of $83.12, trading at $84.88 per share. The average target is based on eight different analyst estimates, ranging from $65 to $94 [1][2].

The recent price surge follows the company's strong second-quarter 2025 results. ANI Pharmaceuticals reported an adjusted earnings per share (EPS) of $1.80, surpassing the FactSet consensus estimate of $1.41. Revenue also exceeded expectations, reaching $211.4 million compared to the forecast of $187.34 million [1][2].

A significant contributor to the strong financial performance was Cortrophin Gel, which generated $81.6 million in revenue, marking a 66% year-over-year increase and a 54% sequential rise from Q1 2025. The company has raised its guidance for Cortrophin Gel to between $322 million and $329 million for 2025 [2].

Analysts have responded to these results with increased price targets. Truist Securities raised its price target to $77.00 from $65.00, maintaining a Hold rating, while H.C. Wainwright increased its target to $93.00 from $84.00, maintaining a Buy rating [1][2].

Investors should assess ANI Pharmaceuticals' valuation and decide whether the stock has become overvalued or if there is room for further growth. The company's strong performance and positive outlook from analysts suggest continued growth potential.

References:
[1] https://www.investing.com/news/analyst-ratings/ani-pharmaceuticals-stock-price-target-raised-to-77-from-65-at-truist-securities-93CH-4183314
[2] https://www.investing.com/news/analyst-ratings/ani-pharmaceuticals-stock-price-target-raised-to-93-from-84-at-hc-wainwright-93CH-4182592